ASLN

ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN

Overview Fund Activity
Delisted

ASLN was delisted on the 18th of July, 2024.

Back to rankings

24 hedge funds and large institutions have $6.58M invested in ASLAN Pharmaceuticals Limited American Depositary Shares in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 8 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
24
Holders Change
-3
Holders Change %
-11.11%
% of All Funds
0.39%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
5
Reduced
8
Closed
5
Calls
$1K
Puts
–
Net Calls
+$1K
Net Calls Change
-$1K

Top Buyers

1
Citigroup
Citigroup
New York
$104K
2
VF
Virtu Financial
New York
$32K
3
Millennium Management
Millennium Management
New York
$595K
4
Citadel Advisors
Citadel Advisors
Florida
$971K
5
Goldman Sachs
Goldman Sachs
New York
$5.12K

Top Sellers

1
RI
RTW Investments
New York
$0
2
TCM
Tang Capital Management
California
$1.93M
3
MA
MYDA Advisors
New York
$0
4
PIM
Platinum Investment Management
Australia
$0
5
WW
Waterfront Wealth
Kansas
$210K
Name Holding Trade Value Shares
Change 		Shares
Change %
MA
26
MYDA Advisors
New York
– -$90K -3,750 Closed
PIM
27
Platinum Investment Management
Australia
– -$87K -3,639 Closed
CL
28
CSS LLC
Illinois
– -$9K -355 Closed
Royal Bank of Canada
29
Royal Bank of Canada
Ontario, Canada
– -$2K -100 Closed
1
2